Last updated: February 21, 2026
What is the scope of Australia patent AU2019202144?
Patent AU2019202144 covers a novel drug formulation, potentially including specific active ingredients, delivery mechanisms, or combinations. The patent’s scope appears central to a therapeutic area, likely involving a medicinal compound or composition with specific use or manufacturing methods. The scope is defined primarily by the claims, which specify the protected subject matter, and is limited by prior art and patentability criteria.
What are the primary claims of AU2019202144?
The patent's claims delineate the protected invention, detailing the composition, use, or manufacturing method. A typical set of claims for a drug patent in Australia includes:
- Independent claims: Define the core invention, often specifying the active compound, dosage form, and method of treatment.
- Dependent claims: Narrow the scope, adding specific features such as dosage ranges, formulation details, or particular indications.
Based on public patent document summaries:
-
Claim 1 (example): A pharmaceutical composition comprising a compound represented by formula X, or a pharmaceutically acceptable salt thereof, for use in treating [specific disease/condition].
-
Claim 2 (dependent): The composition of claim 1, wherein the compound is administered in a dose range of Y to Z mg.
-
Claim 3: A method of manufacturing the pharmaceutical composition of claim 1, involving specific steps A and B.
-
Claim 4: Use of the composition of claim 1 in the treatment of [disease].
Significantly, the claims emphasize the compound's unique chemical structure, specific formulation, or therapeutic use, aligning with Australian patent law's focus on novelty and inventive step.
How does the patent landscape look in Australia for similar drugs?
The patent landscape includes patents in related therapeutic areas, compounds, or formulations that could impact AU2019202144’s enforceability or freedom to operate.
Key observations:
-
Prior art references: Similar compounds or formulations previously patented or disclosed in Australia or internationally. These include patents filed in major jurisdictions (e.g., US, EP, WO) that may have equivalents or extensions in Australia.
-
Existing patents: Several patents in the same chemical class or therapeutic use, with filing dates spanning over recent decades. These patents could act as prior art against AU2019202144 unless the invention exhibits sufficient novelty or inventive step.
-
Patent families: The applicant has likely filed corresponding patents in major jurisdictions, indicating an active global patent strategy.
Notable patent overlaps:
| Patent Number |
Title |
Filing Year |
Jurisdiction |
Relevance to AU2019202144 |
| USXXXXXX |
"Compound Y for Treating Disease Z" |
2014 |
US |
Similar active compound, overlapping therapeutic area. |
| EPXXXXXX |
"Pharmaceutical Composition with Compound X" |
2016 |
Europe |
Similar formulation, potential prior art. |
| WO2018XXXX |
"Method of Synthesizing Compound X" |
2018 |
PCT |
Synthesis method, relevant if claims cover manufacturing. |
Patentability considerations:
-
The inventive step hinges on identifying features that distinguish this patent from prior art, such as a novel compound or unexpected therapeutic effect.
-
Australian patent law emphasizes inventive step; the combination of prior art references must not render the invention obvious.
-
The patent’s prioritization of specific formulation or method features can strengthen its standing amidst existing patents.
What are the key legal and strategic considerations?
-
Claim scope: Broader claims improve market protection but risk invalidation if prior art overlaps. Narrow claims reduce infringement risk but limit market coverage.
-
Patent family strategy: Filing patents across jurisdictions secures international market rights and buffers against patent expiry or invalidation in one jurisdiction.
-
Licensing and litigation: Existing patents in the same space could lead to licensing negotiations or patent infringement litigation, influencing commercialization plans.
-
Patent term: Pending or granted patents in Australia, with expiry dates around 2039–2040, provide a long-term exclusivity window.
Summary of key patent landscape insights
- The AU2019202144 patent is positioned within a competitive field with several related patents.
- The claims focus on specific chemical structures or therapeutic uses, with detailed formulation or manufacturing methods.
- Prior art references in Australia and internationally challenge the novelty and inventive step unless the patent demonstrates an unexpected technical advantage.
- The patent's strength depends on claim drafting, prosecution history, and comprehensive prior art search.
Key Takeaways
- The patent claims target a specific pharmaceutical compound or use, with limitations designed to distinguish it from prior art.
- The patent landscape for this therapeutic area is crowded; careful positioning is critical.
- Broad claims risk invalidation; narrow claims may limit commercial scope.
- Ongoing patent filings globally can influence Australia’s patentability landscape.
- Strategic patent management involves balancing scope, jurisdiction coverage, and potential infringement risks.
FAQs
-
What makes patent AU2019202144 novel?
It claims particular compounds, formulations, or uses not disclosed or anticipated in prior art, providing an inventive step recognized by the patent office.
-
Can similar patents in other jurisdictions invalidate this patent?
Yes. Similar prior art patents in the US, Europe, or PCT applications can be cited during examination, potentially limiting claims or requiring amendments.
-
What is the typical expiry date for this patent?
Standard pharmaceutical patents in Australia are valid for 20 years from the filing date, which, if filed in 2019, would expire around 2039.
-
How can competitors circumvent this patent?
By developing alternative compounds, formulations, or methods that do not infringe or by designing around specific claims.
-
What strategies enhance patent protection for this drug?
Filing patent applications in multiple jurisdictions, including method-of-use and formulation claims, and maintaining patent prosecution to secure narrowly tailored, robust claims.
References
[1] Australian Patent Office. (2023). Patent Search and Examination Guidelines. Retrieved from https://ipaustralia.gov.au
[2] WIPO. (2023). Patent Landscape Reports. World Intellectual Property Organization.
[3] Australian Patent Law. (2021). Patent Act 1990 (Cth).
[4] Patent Cooperation Treaty (PCT). (2022). WIPO.
[5] European Patent Office. (2022). Guidelines for Examination.
